“BD repeatedly painted a misleading picture of its Alaris infusion pump for investors and then doubled down by keeping them in the dark when the device’s issues came to a head with the FDA in ...
BD will pay a $175 million civil penalty to settle charges from the Securities and Exchange Commission that the company misled investors about problems with its Alaris infusion pumps. The SEC ...
Hosted on MSN1mon
Becton Dickinson settles charges over infusion pump risks, SEC saysWASHINGTON (Reuters) - The U.S. Securities and Exchange Commission said on Monday that it had settled charges with Becton Dickinson and Co. (BD ... with its Alaris infusion pump.
(See this PubCo post.) According to Sanjay Wadhwa, Acting Director of SEC Enforcement, “BD repeatedly painted a misleading picture of its Alaris infusion pump for investors and then doubled down ...
Becton, Dickinson and Co. reached an agreement with the U.S. Securities and Exchange Commission (SEC) to resolve an investigation related to allegations that the company misled investors regarding the ...
Becton, Dickinson And Co. Agrees To Pay $175 Million Civil Penalty "BD repeatedly painted a misleading picture of its Alaris infusion pump for investors and then doubled down by keeping them in ...
WASHINGTON (Reuters) - The U.S. Securities and Exchange Commission said on Monday that it had settled charges with Becton Dickinson and Co. (BD) over allegations it misled investors about risks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results